Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jigna Shah

Showing results (21-30 of 48) with videos related to

Pageof 5
Sort By:
ACS Chemical Neuroscience|May 25, 2023
Uncovering Novel Therapeutic Targets for Parkinson's DiseaseRitu Soni, Prashant Delvadia, Amit Joharapurkar, et al.
Drug Delivery and Translational Research|August 15, 2024
Quality by design driven development of lipid nanoparticles for cutaneous targeting: a preliminary approachViral Patel, Tejal Mehta, Jigna Shah, et al.
Applied and Environmental Microbiology|September 7, 2014
Genetic mechanisms underlying the pathogenicity of cold-stressed Salmonella enterica serovar typhimurium in cultured intestinal epithelial cellsJigna Shah, Prerak T Desai, Bart C Weimer
Molecular and Cellular Biochemistry|January 7, 2023
Beneficial effects of buspirone in endothelin-1 induced stroke cachexia in ratsDarshak Shah, Mit Joshi, Jigna Shah, et al.
ACS Chemical Neuroscience|March 24, 2025
Upregulation of the PI3K/AKT and Nrf2 Pathways by the DPP-4 Inhibitor Sitagliptin Renders Neuroprotection in Chemically Induced Parkinson's Disease Mouse ModelsRitu Soni, Vaishali Pankaj, Sudeep Roy, et al.
ACS Pharmacology & Translational Science|December 19, 2024
Hyperglycemia-Driven Insulin Signaling Defects Promote Parkinson's Disease-like Pathology in MiceRitu Soni, Kirti Mathur, Hritik Rathod, et al.
Current Neurovascular Research|September 12, 2022
Insights of Valacyclovir in Treatment of Alzheimer's Disease: Computational Docking Studies and Scopolamine Rat ModelParmi Patel, Khushboo Faldu, Ankit Borisa, et al.
Ageing Research Reviews|April 29, 2026
Tiny Titans, Big Promise: Nanotechnology and microRNA in the Fight Against Alzheimer's DiseaseBhavya Nakum, Dhruvi Vejpara, Khushboo Faldu, et al.
ACS Pharmacology & Translational Science|June 18, 2026
Phosphatidylinositol-3-kinase/Protein Kinase B (PI3K/AKT) and Nucleotide-Binding Oligomerization Domain-like Receptor Family Pyrin Domain Containing 3 (NLRP3) Inflammasome Modulation Underlies the Neuroprotective Effects of Vildagliptin in a Rotenone-Induced Mouse Model of Parkinson's DiseaseDishank Patel, Ritu Soni, Inderjeet Bhogal, et al.
International Journal of Biological Macromolecules|July 4, 2025
GLP1 secretagogue cinnamaldehyde upregulates GLP1/PI3K/AKT and Nrf2 pathways to exert neuroprotection in a rotenone induced mouse model of Parkinson's diseaseKirti Mathur, Ritu Soni, Ruchi Yadav, et al.
Pageof 5

Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
ACS Chemical Neuroscience|May 25, 2023
Uncovering Novel Therapeutic Targets for Parkinson's DiseaseRitu Soni, Prashant Delvadia, Amit Joharapurkar, et al.
Drug Delivery and Translational Research|August 15, 2024
Quality by design driven development of lipid nanoparticles for cutaneous targeting: a preliminary approachViral Patel, Tejal Mehta, Jigna Shah, et al.
Applied and Environmental Microbiology|September 7, 2014
Genetic mechanisms underlying the pathogenicity of cold-stressed Salmonella enterica serovar typhimurium in cultured intestinal epithelial cellsJigna Shah, Prerak T Desai, Bart C Weimer
Molecular and Cellular Biochemistry|January 7, 2023
Beneficial effects of buspirone in endothelin-1 induced stroke cachexia in ratsDarshak Shah, Mit Joshi, Jigna Shah, et al.
ACS Chemical Neuroscience|March 24, 2025
Upregulation of the PI3K/AKT and Nrf2 Pathways by the DPP-4 Inhibitor Sitagliptin Renders Neuroprotection in Chemically Induced Parkinson's Disease Mouse ModelsRitu Soni, Vaishali Pankaj, Sudeep Roy, et al.
ACS Pharmacology & Translational Science|December 19, 2024
Hyperglycemia-Driven Insulin Signaling Defects Promote Parkinson's Disease-like Pathology in MiceRitu Soni, Kirti Mathur, Hritik Rathod, et al.
Current Neurovascular Research|September 12, 2022
Insights of Valacyclovir in Treatment of Alzheimer's Disease: Computational Docking Studies and Scopolamine Rat ModelParmi Patel, Khushboo Faldu, Ankit Borisa, et al.
Ageing Research Reviews|April 29, 2026
Tiny Titans, Big Promise: Nanotechnology and microRNA in the Fight Against Alzheimer's DiseaseBhavya Nakum, Dhruvi Vejpara, Khushboo Faldu, et al.
ACS Pharmacology & Translational Science|June 18, 2026
Phosphatidylinositol-3-kinase/Protein Kinase B (PI3K/AKT) and Nucleotide-Binding Oligomerization Domain-like Receptor Family Pyrin Domain Containing 3 (NLRP3) Inflammasome Modulation Underlies the Neuroprotective Effects of Vildagliptin in a Rotenone-Induced Mouse Model of Parkinson's DiseaseDishank Patel, Ritu Soni, Inderjeet Bhogal, et al.
International Journal of Biological Macromolecules|July 4, 2025
GLP1 secretagogue cinnamaldehyde upregulates GLP1/PI3K/AKT and Nrf2 pathways to exert neuroprotection in a rotenone induced mouse model of Parkinson's diseaseKirti Mathur, Ritu Soni, Ruchi Yadav, et al.
Pageof 5